BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25273097)

  • 1. A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.
    Delville M; Sigdel TK; Wei C; Li J; Hsieh SC; Fornoni A; Burke GW; Bruneval P; Naesens M; Jackson A; Alachkar N; Canaud G; Legendre C; Anglicheau D; Reiser J; Sarwal MM
    Sci Transl Med; 2014 Oct; 6(256):256ra136. PubMed ID: 25273097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors.
    Rashmi P; Sigdel TK; Rychkov D; Damm I; Da Silva AA; Vincenti F; Lourenco AL; Craik CS; Reiser J; Sarwal MM
    Ann Transl Med; 2023 Jun; 11(9):315. PubMed ID: 37404982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis.
    Beaudreuil S; Zhang X; Kriaa F; Dantal J; Francois H; Vazquez A; Charpentier B; Lorenzo HK; Durrbach A
    Nephrol Dial Transplant; 2014 Feb; 29(2):458-63. PubMed ID: 24235085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years' experience.
    Cleper R; Krause I; Bar Nathan N; Mor M; Dagan A; Weissman I; Frishberg Y; Rachamimov R; Mor E; Davidovits M
    Clin Transplant; 2016 Oct; 30(10):1324-1331. PubMed ID: 27490751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
    Shoji J; Mii A; Terasaki M; Shimizu A
    Nephron; 2020; 144 Suppl 1():65-70. PubMed ID: 33260184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients.
    Srivastava P; Solanki AK; Arif E; Wolf BJ; Janech MG; Budisavljevic MN; Kwon SH; Nihalani D
    Kidney Int; 2019 Mar; 95(3):708-716. PubMed ID: 30709661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab.
    Alachkar N; Li J; Matar D; Vujjini V; Alasfar S; Tracy M; Reiser J; Wei C
    BMC Nephrol; 2018 Dec; 19(1):361. PubMed ID: 30558559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation.
    Harel E; Shoji J; Abraham V; Miller L; Laszik Z; Thurison T; King A; Olshen A; Leung J; Szabo G; Hann B; Høyer-Hansen G; Craik CS; Vincenti F
    Clin Transplant; 2019 Mar; 33(3):e13487. PubMed ID: 30689221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence.
    Mujtaba MA; Sharfuddin AA; Book BL; Goggins WC; Khalil AA; Mishler DP; Fridell JA; Yaqub MS; Taber TE
    Clin Transplant; 2015 Jul; 29(7):606-11. PubMed ID: 25973696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria.
    Abuzeineh M; Aala A; Alasfar S; Alachkar N
    BMC Nephrol; 2020 Jul; 21(1):253. PubMed ID: 32615995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated genomic, transcriptomic and metabolomic analysis reveals MDH2 mutation-induced metabolic disorder in recurrent focal segmental glomerulosclerosis.
    Shen Q; Teng L; Wang Y; Guo L; Xu F; Huang H; Xie W; Zhou Q; Chen Y; Wang J; Mao Y; Chen J; Jiang H
    Front Immunol; 2022; 13():962986. PubMed ID: 36159820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
    Kolonko A; Piecha G; Więcek A
    Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to plasma exchange and graft survival in recurrent focal and segmental glomerulosclerosis after transplantation: does the time of recurrence matter? A retrospective study.
    Dudreuilh C; Barbet C; Gatault P; Ferlicot S; Lebranchu Y; Rabot N; Beaudreuil S; Dürrbach A; Büchler M
    Transpl Int; 2021 Feb; 34(2):302-312. PubMed ID: 33275815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
    Doublier S; Zennaro C; Musante L; Spatola T; Candiano G; Bruschi M; Besso L; Cedrino M; Carraro M; Ghiggeri GM; Camussi G; Lupia E
    PLoS One; 2017; 12(11):e0188045. PubMed ID: 29155846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.
    Franco Palacios CR; Lieske JC; Wadei HM; Rule AD; Fervenza FC; Voskoboev N; Garovic VD; Zand L; Stegall MD; Cosio FG; Amer H
    Transplantation; 2013 Aug; 96(4):394-9. PubMed ID: 23736353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.
    Alachkar N; Wei C; Arend LJ; Jackson AM; Racusen LC; Fornoni A; Burke G; Rabb H; Kakkad K; Reiser J; Estrella MM
    Transplantation; 2013 Oct; 96(7):649-56. PubMed ID: 23842190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.
    Dall'Amico R; Ghiggeri G; Carraro M; Artero M; Ghio L; Zamorani E; Zennaro C; Basile G; Montini G; Rivabella L; Cardillo M; Scalamogna M; Ginevri F
    Am J Kidney Dis; 1999 Dec; 34(6):1048-55. PubMed ID: 10585314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble urokinase receptor and focal segmental glomerulosclerosis.
    Reiser J; Wei C; Tumlin J
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):428-32. PubMed ID: 22569341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels.
    Jin J; Li YW; He Q
    Transplant Proc; 2015; 47(6):1760-5. PubMed ID: 26293047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects.
    Weber S; Tönshoff B
    Transplantation; 2005 Sep; 80(1 Suppl):S128-34. PubMed ID: 16286890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.